Terms: = Ovarian cancer AND SMO, Q99835, 6608, ENSG00000128602, SMOH, Gx AND Treatment
14 results:
1. HERC4 modulates ovarian cancer cell proliferation by regulating smo-elicited hedgehog signaling.
Zhu Q; Yang X; Lv Y
Biochim Biophys Acta Gen Subj; 2024 Apr; 1868(4):130557. PubMed ID: 38181892
[TBL] [Abstract] [Full Text] [Related]
2. [Effects of a novel spermine oxidase inhibitor SI-4650 on proliferation and EMT of human ovarian cancer SKVO-3 cells].
Yang JL; Tian JJ; Zhang H; Chen QY; Lyu YF; Cao CY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2022 Mar; 38(2):175-180. PubMed ID: 36031578
[No Abstract] [Full Text] [Related]
3. Sonic Hedgehog signaling pathway in gynecological and genitourinary cancer (Review).
Kotulak-Chrząszcz A; Kmieć Z; Wierzbicki PM
Int J Mol Med; 2021 Jun; 47(6):. PubMed ID: 33907821
[TBL] [Abstract] [Full Text] [Related]
4. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
Katoh M
Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
[TBL] [Abstract] [Full Text] [Related]
5. The role of the Hedgehog signaling pathway in cancer: A comprehensive review.
Skoda AM; Simovic D; Karin V; Kardum V; Vranic S; Serman L
Bosn J Basic Med Sci; 2018 Feb; 18(1):8-20. PubMed ID: 29274272
[TBL] [Abstract] [Full Text] [Related]
6. Non-canonical Hedgehog signaling activation in ovarian borderline tumors and ovarian carcinomas.
Ozretić P; Trnski D; Musani V; Maurac I; Kalafatić D; Orešković S; Levanat S; Sabol M
Int J Oncol; 2017 Dec; 51(6):1869-1877. PubMed ID: 29039491
[TBL] [Abstract] [Full Text] [Related]
7. Patient-derived ovarian cancer xenografts re-growing after a cisplatinum treatment are less responsive to a second drug re-challenge: a new experimental setting to study response to therapy.
Ricci F; Fratelli M; Guffanti F; Porcu L; Spriano F; Dell'Anna T; Fruscio R; Damia G
Oncotarget; 2017 Jan; 8(5):7441-7451. PubMed ID: 26910918
[TBL] [Abstract] [Full Text] [Related]
8. Molecular mechanism of anticancer effect of Sclerotium rolfsii lectin in HT29 cells involves differential expression of genes associated with multiple signaling pathways: A microarray analysis.
Barkeer S; Guha N; Hothpet V; Saligrama Adavigowda D; Hegde P; Padmanaban A; Yu LG; Swamy BM; Inamdar SR
Glycobiology; 2015 Dec; 25(12):1375-91. PubMed ID: 26347523
[TBL] [Abstract] [Full Text] [Related]
9. Sonidegib: First Global Approval.
Burness CB
Drugs; 2015 Sep; 75(13):1559-66. PubMed ID: 26323341
[TBL] [Abstract] [Full Text] [Related]
10. The presence of primary cilia in cancer cells does not predict responsiveness to modulation of smoothened activity.
Spann AL; Yuan K; Goliwas KF; Steg AD; Kaushik DD; Kwon YJ; Frost AR
Int J Oncol; 2015 Jul; 47(1):269-79. PubMed ID: 25997440
[TBL] [Abstract] [Full Text] [Related]
11. Survival of Patients With Mucinous ovarian Carcinoma and ovarian Metastases: A Population-Based cancer Registry Study.
Simons M; Ezendam N; Bulten J; Nagtegaal I; Massuger L
Int J Gynecol Cancer; 2015 Sep; 25(7):1208-15. PubMed ID: 25978291
[TBL] [Abstract] [Full Text] [Related]
12. smoothened antagonists reverse taxane resistance in ovarian cancer.
Steg AD; Katre AA; Bevis KS; Ziebarth A; Dobbin ZC; Shah MM; Alvarez RD; Landen CN
Mol Cancer Ther; 2012 Jul; 11(7):1587-97. PubMed ID: 22553355
[TBL] [Abstract] [Full Text] [Related]
13. Characterization of Pt-, Pd-spermine complexes for their effect on polyamine pathway and cisplatin resistance in A2780 ovarian carcinoma cells.
Tummala R; Diegelman P; Fiuza SM; Batista de Carvalho LA; Marques MP; Kramer DL; Clark K; Vujcic S; Porter CW; Pendyala L
Oncol Rep; 2010 Jul; 24(1):15-24. PubMed ID: 20514439
[TBL] [Abstract] [Full Text] [Related]
14. Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it's inhibition leads to growth suppression and apoptosis.
Chen X; Horiuchi A; Kikuchi N; Osada R; Yoshida J; Shiozawa T; Konishi I
Cancer Sci; 2007 Jan; 98(1):68-76. PubMed ID: 17083567
[TBL] [Abstract] [Full Text] [Related]